medRxivGenetic & Genomic MedicinePreprint
LynchRisk: a Bayesian network to estimate the probability of Lynch syndrome based on pedigree and tumor characteristics
Alexandra LefebvreiD, Patrick R. BenusiglioiD, Grégory NueliD
Abstract
BackgroundCurrent Lynch syndrome (LS) prediction models do not account for detailed family structure and tumour mismatch repair (MMR) status. We developed LynchRisk, a Bayesian model that estimates individualized LS probability from pedigree, cancer history and tumour MMR test results. MethodsLynchRisk combines Mendelian inheritance, age- and sex-specific cancer hazards, affected and unaffected relatives, and detailed MMR status. Parameters were derived from the literature. ResultsIn two simulated cases of probands with LS-associated cancers, family structure and MMR status markedly changed LS probability estimates, with implications for germline testing decisions. LynchRisk also identified situations in which a negative germline result might be considered sufficient to rule out LS or, conversely, prompt further investigations such as somatic MMR or long-read sequencing. DiscussionLynchRisk gives individualized LS probability by combining clinical, family, and tumour data at different stages of the diagnostic process. Further work will focus on recalibrating cancer hazard functions, validating model performance through simulations, and developing an R package for use by interested research groups.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Estimating cancer risk in carriers of Lynch syndrome variants in UK Biobank
Eilidh Fummey, Pau Navarro, … Albert Tenesa·Journal of Medical GeneticsPeer-reviewed·Jul 14, 2024
- Ability of a polygenic risk score to refine colorectal cancer risk in Lynch syndrome
Núria Dueñas, Hannah Klinkhammer, … Joan Brunet·Journal of Medical GeneticsPeer-reviewed·Jun 15, 2023
- Cancer risks for MSH6 pathogenic variant carriers
A.S. van der Werf – ‘t Lam, James G. Dowty, … Maartje Nielsen·medRxiv·Feb 15, 2025
- Risk of differential cancer types over age in families with Li-Fraumeni syndrome: a validation study using multi-center cohorts
Seung Jun Shin, Elissa B. Dodd-Eaton, … Wenyi Wang·bioRxiv·Mar 5, 2019
- Risk of multiple primary cancer diagnosis over age in families of Li-Fraumeni syndrome: a single institution perspective
Seung Jun Shin, Elissa B. Dodd-Eaton, … Wenyi Wang·Cancer ResearchPeer-reviewed·Nov 12, 2019
- Lynch syndrome in the general population: low clinical utility of genomic screening for PMS2 pathogenic variants
Kelly M. Schiabor Barrett, Catherine A. Hajek, … Alexandre Bolze·medRxiv·Feb 3, 2025